# Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma

> **NCT01208194** · PHASE2 · COMPLETED · sponsor: **Mologen AG** · enrollment: 59 (actual)

## Conditions studied

- Advanced Colorectal Carcinoma

## Interventions

- **DRUG:** MGN1703
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01208194
- **Lead sponsor:** Mologen AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208194, "Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01208194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*